Filed: 8/11/2023ACC: 0001104659-23-090491
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $625.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$625.36M
Total AUM (reported)
76.93M
Total Shares
Allocation by class
COM$542.28M86.7%
ORDINARY SHARES$41.73M6.7%
SPONSORED ADS$40.90M6.5%
COM NEW$444.0K0.1%
Portfolio Concentration
Top 3$183.01M29.3%
4–10$251.34M40.2%
11–25$183.56M29.4%
Rest$7.46M1.2%
Top 3 weight
29.3%
Top 10 weight
69.5%
Voting Authority Distribution
Total shares with voting rights: 76.93M
Sole
Full voting authority
76.93M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
VIRIDIAN THERAPEUTICS INC
SOLEShares3.08M
TypeSH
Market value$73.34M
11.73%
Sole
3.08M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.68M
TypeSH
Market value$55.46M
8.87%
Sole
4.68M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares3M
TypeSH
Market value$54.21M
8.67%
Sole
3M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares2.23M
TypeSH
Market value$45.52M
7.28%
Sole
2.23M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.73M
TypeSH
Market value$45.45M
7.27%
Sole
1.73M
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares3.52M
TypeSH
Market value$41.73M
6.67%
Sole
3.52M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares2.48M
TypeSH
Market value$40.90M
6.54%
Sole
2.48M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.92M
TypeSH
Market value$26.25M
4.20%
Sole
2.92M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares2.97M
TypeSH
Market value$26.01M
4.16%
Sole
2.97M
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.97M
TypeSH
Market value$25.47M
4.07%
Sole
1.97M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$24.46M
3.91%
Sole
2.17M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.11M
TypeSH
Market value$23.12M
3.70%
Sole
2.11M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares6.35M
TypeSH
Market value$20.29M
3.25%
Sole
6.35M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.33M
TypeSH
Market value$20.08M
3.21%
Sole
1.33M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$17.97M
2.87%
Sole
1.09M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.14M
TypeSH
Market value$16.63M
2.66%
Sole
2.14M
Shared
0.00
None
0.00
ACLARIS THERAPEUTICS INC
SOLEShares1.04M
TypeSH
Market value$10.79M
1.73%
Sole
1.04M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares3.42M
TypeSH
Market value$8.18M
1.31%
Sole
3.42M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares5.66M
TypeSH
Market value$7.24M
1.16%
Sole
5.66M
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares770K
TypeSH
Market value$7.18M
1.15%
Sole
770K
Shared
0.00
None
0.00
MILESTONE PHARMACEUTICALS IN
SOLEShares2.21M
TypeSH
Market value$6.30M
1.01%
Sole
2.21M
Shared
0.00
None
0.00
ADVERUM BIOTECHNOLOGIES INC
SOLEShares3.89M
TypeSH
Market value$6.18M
0.99%
Sole
3.89M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares5.30M
TypeSH
Market value$6.10M
0.98%
Sole
5.30M
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares288.95K
TypeSH
Market value$5.24M
0.84%
Sole
288.95K
Shared
0.00
None
0.00
LYRA THERAPEUTICS INC
SOLEShares924.17K
TypeSH
Market value$3.80M
0.61%
Sole
924.17K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.08M | SH | $73.34M 11.73% | 3.08M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.68M | SH | $55.46M 8.87% | 4.68M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 3M | SH | $54.21M 8.67% | 3M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 2.23M | SH | $45.52M 7.28% | 2.23M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.73M | SH | $45.45M 7.27% | 1.73M | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 3.52M | SH | $41.73M 6.67% | 3.52M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 2.48M | SH | $40.90M 6.54% | 2.48M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.92M | SH | $26.25M 4.20% | 2.92M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 2.97M | SH | $26.01M 4.16% | 2.97M | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.97M | SH | $25.47M 4.07% | 1.97M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $24.46M 3.91% | 2.17M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.11M | SH | $23.12M 3.70% | 2.11M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 6.35M | SH | $20.29M 3.25% | 6.35M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.33M | SH | $20.08M 3.21% | 1.33M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $17.97M 2.87% | 1.09M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.14M | SH | $16.63M 2.66% | 2.14M | 0.00 | 0.00 |
ACLARIS THERAPEUTICS INCSOLE | COM | 1.04M | SH | $10.79M 1.73% | 1.04M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 3.42M | SH | $8.18M 1.31% | 3.42M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 5.66M | SH | $7.24M 1.16% | 5.66M | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 770K | SH | $7.18M 1.15% | 770K | 0.00 | 0.00 |
MILESTONE PHARMACEUTICALS INSOLE | COM | 2.21M | SH | $6.30M 1.01% | 2.21M | 0.00 | 0.00 |
ADVERUM BIOTECHNOLOGIES INCSOLE | COM | 3.89M | SH | $6.18M 0.99% | 3.89M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM | 5.30M | SH | $6.10M 0.98% | 5.30M | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 288.95K | SH | $5.24M 0.84% | 288.95K | 0.00 | 0.00 |
LYRA THERAPEUTICS INCSOLE | COM | 924.17K | SH | $3.80M 0.61% | 924.17K | 0.00 | 0.00 |
Page 1 of 2